News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
703,521 Results
Type
Article (60923)
Company Profile (100)
Press Release (642498)
Section
Business (197727)
Career Advice (3008)
Deals (34691)
Drug Delivery (108)
Drug Development (82043)
Employer Resources (172)
FDA (16061)
Job Trends (15060)
News (339739)
Policy (32807)
Tag
2024 BioCapital Digital (4)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
Academia (2761)
Academic (2)
Accelerated approval (3)
Adcomms (24)
Allergies (88)
Alliances (49363)
ALS (86)
Alzheimer's disease (1362)
Antibody-drug conjugate (ADC) (109)
Approvals (16056)
Artificial intelligence (258)
Autoimmune disease (20)
Automation (14)
Bankruptcy (316)
Best Places to Work (11652)
BIOSECURE Act (19)
Biosimilars (108)
Biotechnology (70)
Bladder cancer (62)
Brain cancer (27)
Breast cancer (252)
Cancer (2044)
Cardiovascular disease (168)
Career advice (2543)
Career pathing (33)
CAR-T (149)
Cell therapy (423)
Cervical cancer (20)
Clinical research (66271)
Collaboration (786)
Compensation (323)
Complete response letters (24)
COVID-19 (2633)
CRISPR (40)
C-suite (230)
Cystic fibrosis (101)
Data (1977)
Decentralized trials (2)
Denatured (35)
Depression (38)
Diabetes (252)
Diagnostics (6422)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (107)
Drug shortages (27)
Duchenne muscular dystrophy (83)
Earnings (76031)
Editorial (37)
Employer branding (21)
Employer resources (150)
Events (107591)
Executive appointments (683)
FDA (17206)
Featured Employer (37)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (707)
Gene editing (102)
Generative AI (25)
Gene therapy (292)
GLP-1 (730)
Government (4739)
Grass and pollen (5)
Guidances (46)
Healthcare (19230)
Huntington's disease (18)
IgA nephropathy (24)
Immunology and inflammation (127)
Indications (27)
Infectious disease (2763)
Inflammatory bowel disease (141)
Inflation Reduction Act (11)
Influenza (51)
Intellectual property (89)
Interviews (576)
IPO (15829)
IRA (44)
Job creations (3847)
Job search strategy (2124)
Kidney cancer (10)
Labor market (29)
Layoffs (509)
Leadership (20)
Legal (7855)
Liver cancer (72)
Lung cancer (294)
Lymphoma (133)
Machine learning (4)
Management (59)
Manufacturing (265)
MASH (63)
Medical device (13204)
Medtech (13209)
Mergers & acquisitions (19380)
Metabolic disorders (647)
Multiple sclerosis (74)
NASH (17)
Neurodegenerative disease (84)
Neuropsychiatric disorders (25)
Neuroscience (1850)
NextGen: Class of 2025 (6803)
Non-profit (4717)
Northern California (2322)
Now hiring (14)
Obesity (341)
Opinion (246)
Ovarian cancer (68)
Pain (85)
Pancreatic cancer (78)
Parkinson's disease (135)
Partnered (21)
Patents (214)
Patient recruitment (95)
Peanut (51)
People (60349)
Pharmaceutical (28)
Pharmacy benefit managers (19)
Phase I (20563)
Phase II (28992)
Phase III (21719)
Pipeline (1047)
Podcasts (97)
Policy (123)
Postmarket research (2882)
Preclinical (8943)
Press Release (67)
Prostate cancer (97)
Psychedelics (31)
Radiopharmaceuticals (258)
Rare diseases (367)
Real estate (6268)
Recruiting (68)
Regulatory (22230)
Reports (40)
Research institute (2431)
Resumes & cover letters (460)
Rett syndrome (3)
RNA editing (4)
RSV (40)
Schizophrenia (69)
Series A (129)
Series B (78)
Service/supplier (9)
Sickle cell disease (54)
Southern California (2028)
Special edition (15)
Spinal muscular atrophy (153)
Sponsored (30)
Startups (3452)
State (1)
Stomach cancer (12)
Supply chain (56)
The Weekly (60)
United States (20670)
Vaccines (684)
Venture capitalists (33)
Webinars (11)
Weight loss (237)
Women's health (34)
Worklife (18)
Date
Today (140)
Last 7 days (728)
Last 30 days (2783)
Last 365 days (33183)
2025 (8248)
2024 (34586)
2023 (38906)
2022 (49680)
2021 (54644)
2020 (53680)
2019 (47578)
2018 (36105)
2017 (33010)
2016 (32853)
2015 (38405)
2014 (32115)
2013 (28334)
2012 (29629)
2011 (29635)
2010 (28547)
Location
Africa (972)
Alabama (54)
Alaska (6)
Arizona (177)
Arkansas (14)
Asia (40919)
Australia (7157)
California (5281)
Canada (1800)
China (487)
Colorado (245)
Connecticut (265)
Delaware (129)
Europe (94812)
Florida (804)
Georgia (198)
Idaho (57)
Illinois (533)
India (24)
Indiana (286)
Iowa (7)
Japan (139)
Kansas (95)
Kentucky (24)
Louisiana (8)
Maine (61)
Maryland (834)
Massachusetts (3981)
Michigan (212)
Minnesota (343)
Mississippi (2)
Missouri (83)
Montana (30)
Nebraska (23)
Nevada (55)
New Hampshire (62)
New Jersey (1591)
New Mexico (30)
New York (1564)
North Carolina (970)
North Dakota (7)
Northern California (2322)
Ohio (184)
Oklahoma (15)
Oregon (34)
Pennsylvania (1187)
Puerto Rico (9)
Rhode Island (24)
South America (1315)
South Carolina (19)
South Dakota (1)
Southern California (2028)
Tennessee (93)
Texas (801)
Utah (167)
Virginia (130)
Washington D.C. (56)
Washington State (498)
West Virginia (3)
Wisconsin (52)
703,521 Results for "american academy of allergy asthma and immunology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress
February 20, 2025
·
2 min read
Press Releases
KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
March 4, 2025
·
7 min read
Press Releases
KalVista Pharmaceuticals to Present New Sebetralstat Data at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
February 21, 2025
·
5 min read
Press Releases
Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
March 3, 2025
·
9 min read
Press Releases
Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
February 10, 2025
·
6 min read
Press Releases
BioCryst to Present New ORLADEYO® (berotralstat) Results from APeX-P Pediatric Trial at 2025 American Academy of Allergy, Asthma & Immunology / World Allergy Organization Joint Congress
February 10, 2025
·
6 min read
Press Releases
ARS Pharmaceuticals to Showcase Innovation and Present Data on neffy® (epinephrine nasal spray) at 2025 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Scientific Meeting
February 19, 2025
·
9 min read
Genetown
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting
Astria Therapeutics, Inc. today announced that it will present final STAR-0215 Phase 1a healthy subject data at the upcoming American Academy of Allergy, Asthma, & Immunology (AAAAI) Annual Meeting in Washington, D.C. on February 23, 2024 at 3:15pm EST.
February 20, 2024
·
1 min read
Pharm Country
Intrommune Therapeutics To Present A New Form Of Allergy Treatment At The 2024 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
Intrommune Therapeutics, Inc. today announced data from The First Study To Evaluate Oral Mucosal Immunotherapy (OMIT) For The Treatment Of Food Allergy has been selected as a Late Breaking Poster Presentation at the 2024 American Academy of Allergy, Asthma & Immunology in Washington, DC.
February 6, 2024
·
3 min read
Drug Development
KalVista Pharmaceuticals to Present Phase 3 Sebetralstat Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
KalVista Pharmaceuticals, Inc. announced the acceptance of multiple abstracts at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting taking place in Washington, DC from February 23-26.
February 16, 2024
·
5 min read
1 of 70,353
Next
